• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
Approval Date:  06/20/2008
Trade Name:  Pentacel
Generic or Proper Name (*):  Diphtheria And Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus B Conjugate (Tetanus Toxoid Conjugate) Vaccine*
Indications Studied:  Active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b
Therapeutic Category:  Preventive Vaccine
Ages Studied:  2 - 17 months
Study #:  5
Study Type:  Safety/Immunogenicity
Study Design:  Open Label
No Patients:  1257
No Centers:  38
No Countries:  1